Skip to content
10-K

Annual Report

Ocular Therapeutix, Inc. OCUL

0001558370-25-002000

← back to feed
Filed
Mar 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 27, 2025 159.02M sh
Current Liabilities FY 2024 · Dec 31, 2023 $34.9M
Total Liabilities FY 2024 · Dec 31, 2023 $160.93M
Current Assets FY 2024 · Dec 31, 2023 $232.24M
Total Assets FY 2024 · Dec 31, 2023 $252.06M
Shares Diluted FY 2024 · Dec 31, 2022 82.64M sh
Capex FY 2024 · Dec 31, 2022 $3.72M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$59.6M
Cash And Equivalents FY 2024 · Dec 31, 2022 $102.3M
Eps Diluted FY 2024 · Dec 31, 2022 −$0.97
Eps Basic FY 2024 · Dec 31, 2022 −$0.92
Sga Expense FY 2024 · Dec 31, 2022 $32.22M
Rd Expense FY 2024 · Dec 31, 2022 $53.46M
Net Income FY 2024 · Dec 31, 2022 −$71.04M
Operating Income FY 2024 · Dec 31, 2022 −$78.65M
Cost Of Revenue FY 2024 · Dec 31, 2022 $4.54M
Revenue FY 2024 · Dec 31, 2022 $51.49M
Stockholders Equity FY 2024 · Dec 31, 2021 $88M